Global Anti-inflammatory Therapeutics Supply, Demand and Key Producers, 2024-2030

Description

The global Anti-inflammatory Therapeutics market size is expected to reach $ 169200 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period (2024-2030).

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

This report studies the global Anti-inflammatory Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-inflammatory Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-inflammatory Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-inflammatory Therapeutics total market, 2019-2030, (USD Million)
Global Anti-inflammatory Therapeutics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-inflammatory Therapeutics total market, key domestic companies and share, (USD Million)
Global Anti-inflammatory Therapeutics revenue by player and market share 2019-2024, (USD Million)
Global Anti-inflammatory Therapeutics total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-inflammatory Therapeutics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Anti-inflammatory Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck and Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-inflammatory Therapeutics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-inflammatory Therapeutics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-inflammatory Therapeutics Market, Segmentation by Type
    Anti-inflammatory Biologics
    Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Corticosteroids
    Others

Global Anti-inflammatory Therapeutics Market, Segmentation by Application
    Arthritis
    Respiratory Diseases
    Dermatology
    Gastroenterology
    Others

Companies Profiled:
    AbbVie
    Johnson & Johnson
    Amgen Inc
    AstraZeneca PLC
    Pfizer, Inc
    Novartis
    Roche
    Merck
    Sanofi
    GlaxoSmithKline
    Sun Pharmaceutical Industries Ltd
    TEVA

Key Questions Answered
1. How big is the global Anti-inflammatory Therapeutics market?
2. What is the demand of the global Anti-inflammatory Therapeutics market?
3. What is the year over year growth of the global Anti-inflammatory Therapeutics market?
4. What is the total value of the global Anti-inflammatory Therapeutics market?
5. Who are the major players in the global Anti-inflammatory Therapeutics market?

Table of Contents

1 Supply Summary
    1.1 Anti-inflammatory Therapeutics Introduction
    1.2 World Anti-inflammatory Therapeutics Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Anti-inflammatory Therapeutics Total Market by Region (by Headquarter Location)
        1.3.1 World Anti-inflammatory Therapeutics Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.3 China Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.4 Europe Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.5 Japan Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.6 South Korea Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.7 ASEAN Anti-inflammatory Therapeutics Market Size (2019-2030)
        1.3.8 India Anti-inflammatory Therapeutics Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-inflammatory Therapeutics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-inflammatory Therapeutics Major Market Trends

2 Demand Summary
    2.1 World Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.2 World Anti-inflammatory Therapeutics Consumption Value by Region
        2.2.1 World Anti-inflammatory Therapeutics Consumption Value by Region (2019-2024)
        2.2.2 World Anti-inflammatory Therapeutics Consumption Value Forecast by Region (2025-2030)
    2.3 United States Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.4 China Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.5 Europe Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.6 Japan Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.7 South Korea Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.8 ASEAN Anti-inflammatory Therapeutics Consumption Value (2019-2030)
    2.9 India Anti-inflammatory Therapeutics Consumption Value (2019-2030)

3 World Anti-inflammatory Therapeutics Companies Competitive Analysis
    3.1 World Anti-inflammatory Therapeutics Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Anti-inflammatory Therapeutics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Anti-inflammatory Therapeutics in 2023
        3.2.3 Global Concentration Ratios (CR8) for Anti-inflammatory Therapeutics in 2023
    3.3 Anti-inflammatory Therapeutics Company Evaluation Quadrant
    3.4 Anti-inflammatory Therapeutics Market: Overall Company Footprint Analysis
        3.4.1 Anti-inflammatory Therapeutics Market: Region Footprint
        3.4.2 Anti-inflammatory Therapeutics Market: Company Product Type Footprint
        3.4.3 Anti-inflammatory Therapeutics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Anti-inflammatory Therapeutics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Anti-inflammatory Therapeutics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Anti-inflammatory Therapeutics Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Anti-inflammatory Therapeutics Consumption Value Comparison
        4.2.1 United States VS China: Anti-inflammatory Therapeutics Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-inflammatory Therapeutics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Anti-inflammatory Therapeutics Companies and Market Share, 2019-2024
        4.3.1 United States Based Anti-inflammatory Therapeutics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024)
    4.4 China Based Companies Anti-inflammatory Therapeutics Revenue and Market Share, 2019-2024
        4.4.1 China Based Anti-inflammatory Therapeutics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024)
    4.5 Rest of World Based Anti-inflammatory Therapeutics Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Anti-inflammatory Therapeutics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-inflammatory Therapeutics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Anti-inflammatory Biologics
        5.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        5.2.3 Corticosteroids
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
        5.3.2 World Anti-inflammatory Therapeutics Market Size by Type (2025-2030)
        5.3.3 World Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-inflammatory Therapeutics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Arthritis
        6.2.2 Respiratory Diseases
        6.2.3 Dermatology
        6.2.4 Gastroenterology
        6.2.5 Gastroenterology
    6.3 Market Segment by Application
        6.3.1 World Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
        6.3.2 World Anti-inflammatory Therapeutics Market Size by Application (2025-2030)
        6.3.3 World Anti-inflammatory Therapeutics Market Size by Application (2019-2030)

7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Details
        7.1.2 AbbVie Major Business
        7.1.3 AbbVie Anti-inflammatory Therapeutics Product and Services
        7.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 AbbVie Recent Developments/Updates
        7.1.6 AbbVie Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Services
        7.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Amgen Inc
        7.3.1 Amgen Inc Details
        7.3.2 Amgen Inc Major Business
        7.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Services
        7.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Amgen Inc Recent Developments/Updates
        7.3.6 Amgen Inc Competitive Strengths & Weaknesses
    7.4 AstraZeneca PLC
        7.4.1 AstraZeneca PLC Details
        7.4.2 AstraZeneca PLC Major Business
        7.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Services
        7.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 AstraZeneca PLC Recent Developments/Updates
        7.4.6 AstraZeneca PLC Competitive Strengths & Weaknesses
    7.5 Pfizer, Inc
        7.5.1 Pfizer, Inc Details
        7.5.2 Pfizer, Inc Major Business
        7.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Services
        7.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Pfizer, Inc Recent Developments/Updates
        7.5.6 Pfizer, Inc Competitive Strengths & Weaknesses
    7.6 Novartis
        7.6.1 Novartis Details
        7.6.2 Novartis Major Business
        7.6.3 Novartis Anti-inflammatory Therapeutics Product and Services
        7.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Novartis Recent Developments/Updates
        7.6.6 Novartis Competitive Strengths & Weaknesses
    7.7 Roche
        7.7.1 Roche Details
        7.7.2 Roche Major Business
        7.7.3 Roche Anti-inflammatory Therapeutics Product and Services
        7.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Roche Recent Developments/Updates
        7.7.6 Roche Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Anti-inflammatory Therapeutics Product and Services
        7.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 Sanofi
        7.9.1 Sanofi Details
        7.9.2 Sanofi Major Business
        7.9.3 Sanofi Anti-inflammatory Therapeutics Product and Services
        7.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Sanofi Recent Developments/Updates
        7.9.6 Sanofi Competitive Strengths & Weaknesses
    7.10 GlaxoSmithKline
        7.10.1 GlaxoSmithKline Details
        7.10.2 GlaxoSmithKline Major Business
        7.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Services
        7.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 GlaxoSmithKline Recent Developments/Updates
        7.10.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.11 Sun Pharmaceutical Industries Ltd
        7.11.1 Sun Pharmaceutical Industries Ltd Details
        7.11.2 Sun Pharmaceutical Industries Ltd Major Business
        7.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Services
        7.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
        7.11.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    7.12 TEVA
        7.12.1 TEVA Details
        7.12.2 TEVA Major Business
        7.12.3 TEVA Anti-inflammatory Therapeutics Product and Services
        7.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 TEVA Recent Developments/Updates
        7.12.6 TEVA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-inflammatory Therapeutics Industry Chain
    8.2 Anti-inflammatory Therapeutics Upstream Analysis
    8.3 Anti-inflammatory Therapeutics Midstream Analysis
    8.4 Anti-inflammatory Therapeutics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Anti-inflammatory Therapeutics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Anti-inflammatory Therapeutics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Anti-inflammatory Therapeutics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Anti-inflammatory Therapeutics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Anti-inflammatory Therapeutics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Anti-inflammatory Therapeutics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Anti-inflammatory Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Anti-inflammatory Therapeutics Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Anti-inflammatory Therapeutics Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Anti-inflammatory Therapeutics Players in 2023
    Table 12. World Anti-inflammatory Therapeutics Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Anti-inflammatory Therapeutics Company Evaluation Quadrant
    Table 14. Head Office of Key Anti-inflammatory Therapeutics Player
    Table 15. Anti-inflammatory Therapeutics Market: Company Product Type Footprint
    Table 16. Anti-inflammatory Therapeutics Market: Company Product Application Footprint
    Table 17. Anti-inflammatory Therapeutics Mergers & Acquisitions Activity
    Table 18. United States VS China Anti-inflammatory Therapeutics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Anti-inflammatory Therapeutics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Anti-inflammatory Therapeutics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Anti-inflammatory Therapeutics Revenue Market Share (2019-2024)
    Table 23. China Based Anti-inflammatory Therapeutics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Anti-inflammatory Therapeutics Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Anti-inflammatory Therapeutics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Anti-inflammatory Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Anti-inflammatory Therapeutics Revenue Market Share (2019-2024)
    Table 29. World Anti-inflammatory Therapeutics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Anti-inflammatory Therapeutics Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Anti-inflammatory Therapeutics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Anti-inflammatory Therapeutics Market Size by Application (2025-2030) & (USD Million)
    Table 35. AbbVie Basic Information, Area Served and Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Anti-inflammatory Therapeutics Product and Services
    Table 38. AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. AbbVie Recent Developments/Updates
    Table 40. AbbVie Competitive Strengths & Weaknesses
    Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 42. Johnson & Johnson Major Business
    Table 43. Johnson & Johnson Anti-inflammatory Therapeutics Product and Services
    Table 44. Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Johnson & Johnson Recent Developments/Updates
    Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 47. Amgen Inc Basic Information, Area Served and Competitors
    Table 48. Amgen Inc Major Business
    Table 49. Amgen Inc Anti-inflammatory Therapeutics Product and Services
    Table 50. Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Amgen Inc Recent Developments/Updates
    Table 52. Amgen Inc Competitive Strengths & Weaknesses
    Table 53. AstraZeneca PLC Basic Information, Area Served and Competitors
    Table 54. AstraZeneca PLC Major Business
    Table 55. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Services
    Table 56. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. AstraZeneca PLC Recent Developments/Updates
    Table 58. AstraZeneca PLC Competitive Strengths & Weaknesses
    Table 59. Pfizer, Inc Basic Information, Area Served and Competitors
    Table 60. Pfizer, Inc Major Business
    Table 61. Pfizer, Inc Anti-inflammatory Therapeutics Product and Services
    Table 62. Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Pfizer, Inc Recent Developments/Updates
    Table 64. Pfizer, Inc Competitive Strengths & Weaknesses
    Table 65. Novartis Basic Information, Area Served and Competitors
    Table 66. Novartis Major Business
    Table 67. Novartis Anti-inflammatory Therapeutics Product and Services
    Table 68. Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Novartis Recent Developments/Updates
    Table 70. Novartis Competitive Strengths & Weaknesses
    Table 71. Roche Basic Information, Area Served and Competitors
    Table 72. Roche Major Business
    Table 73. Roche Anti-inflammatory Therapeutics Product and Services
    Table 74. Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Roche Recent Developments/Updates
    Table 76. Roche Competitive Strengths & Weaknesses
    Table 77. Merck Basic Information, Area Served and Competitors
    Table 78. Merck Major Business
    Table 79. Merck Anti-inflammatory Therapeutics Product and Services
    Table 80. Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Merck Recent Developments/Updates
    Table 82. Merck Competitive Strengths & Weaknesses
    Table 83. Sanofi Basic Information, Area Served and Competitors
    Table 84. Sanofi Major Business
    Table 85. Sanofi Anti-inflammatory Therapeutics Product and Services
    Table 86. Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Sanofi Recent Developments/Updates
    Table 88. Sanofi Competitive Strengths & Weaknesses
    Table 89. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 90. GlaxoSmithKline Major Business
    Table 91. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Services
    Table 92. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. GlaxoSmithKline Recent Developments/Updates
    Table 94. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 95. Sun Pharmaceutical Industries Ltd Basic Information, Area Served and Competitors
    Table 96. Sun Pharmaceutical Industries Ltd Major Business
    Table 97. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Services
    Table 98. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 100. TEVA Basic Information, Area Served and Competitors
    Table 101. TEVA Major Business
    Table 102. TEVA Anti-inflammatory Therapeutics Product and Services
    Table 103. TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 104. Global Key Players of Anti-inflammatory Therapeutics Upstream (Raw Materials)
    Table 105. Anti-inflammatory Therapeutics Typical Customers
List of Figure
    Figure 1. Anti-inflammatory Therapeutics Picture
    Figure 2. World Anti-inflammatory Therapeutics Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Anti-inflammatory Therapeutics Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Anti-inflammatory Therapeutics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Anti-inflammatory Therapeutics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Anti-inflammatory Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 13. Anti-inflammatory Therapeutics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Anti-inflammatory Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Anti-inflammatory Therapeutics by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-inflammatory Therapeutics Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-inflammatory Therapeutics Markets in 2023
    Figure 27. United States VS China: Anti-inflammatory Therapeutics Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Anti-inflammatory Therapeutics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Anti-inflammatory Therapeutics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Anti-inflammatory Therapeutics Market Size Market Share by Type in 2023
    Figure 31. Anti-inflammatory Biologics
    Figure 32. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Figure 33. Corticosteroids
    Figure 34. Others
    Figure 35. World Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2030)
    Figure 36. World Anti-inflammatory Therapeutics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Anti-inflammatory Therapeutics Market Size Market Share by Application in 2023
    Figure 38. Arthritis
    Figure 39. Respiratory Diseases
    Figure 40. Dermatology
    Figure 41. Gastroenterology
    Figure 42. Others
    Figure 43. Anti-inflammatory Therapeutics Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA